ENTPD1 and autoimmune disease: Recent studies have suggested that catalytic inactivation and conversion of the extracellular ATP and ADP to AMP, both induced by CD39, serve as anti-inflammatory mechanisms by which Tregs mediate immune suppression in human autoimmune diseases.